CGST And Central Excise vs. Promed Laboratories LTD.

Held

The Court held that the appeal is liable to be withdrawn as the valuation is less than the enhanced monetary limit of 2 crore, as per the order dated 06.08.2024 issued by the Central Board of Indirect Taxes and Customs. Consequently, the application for withdrawal of the appeal was allowed, and the appeal was dismissed as withdrawn. The Court explicitly clarified that the question of law raised in this appeal shall remain open to be raised at a subsequent stage. The ratio decidendi is that appeals not meeting the enhanced monetary threshold for filing are subject to withdrawal. No specific finding was made on the merits of the original dispute.

Facts

This Central Excise Appeal No. 105 of 2018 was filed by the Revenue Department (CGST and Central Excise) against Promed Laboratories Ltd. The appeal concerns a valuation dispute, though the specific tax period and the order under challenge are not detailed. The procedural history indicates that during the pendency of this appeal, the Central Board of Indirect Taxes and Customs, exercising powers under Section 35R of the Central Excise Act, 1944, read with Section 83 of the Finance Act, 1994, enhanced the monetary limit for filing appeals to the High Court and Supreme Court. As the valuation in this present appeal was less than 2 crore, the appellant (Revenue) filed an application to withdraw the appeal.

Key Issues

1. Whether the appeal is maintainable before this Court given the enhanced monetary limit for filing appeals, as stipulated by the order dated 06.08.2024 issued by the Central Board of Indirect Taxes and Customs under Section 35R of the Central Excise Act, 1944, read with Section 83 of the Finance Act, 1994? The Revenue argued that the appeal is liable to be withdrawn as the valuation is less than the enhanced monetary limit of 2 crore. The Petitioner (Promed Laboratories Ltd.) did not file any specific argument recorded in the judgment.